Fresenius Kabi d.o.o. Beograd

Fresenius Healthcare Services Overview

Fresenius SE & Co. KGaA is a leading global healthcare company based in Bad Homburg, Germany, dedicated to providing innovative solutions and therapies across various fields, including Biosimilars, Infusion and Nutrition Systems, and Clinical Nutrition. With over 176,000 employees, Fresenius is committed to enhancing the quality of life for patients through its advanced medical products and personalized healthcare services.

Key Fields of Work

Fresenius specializes in several therapeutic areas, ensuring comprehensive care for patients:

• Biosimilars: Development of affordable alternatives to biological therapeutics.
• Infusion and Nutrition Systems: Advanced solutions for patient nutrition.
• IV Generics & Fluids: A range of intravenous generics and fluids.
• Clinical Nutrition: Specialized nutritional products for diverse patient needs.
• Transfusion Medicine: Innovative solutions for transfusion and cell therapies.
• Inpatient & Outpatient Treatments: Comprehensive care options across settings.
• Occupational Healthcare: Prevention and health management in the workplace.

Sustainability and Corporate Governance

Fresenius believes in sustainable operations guided by corporate governance and compliance. The company prioritizes ethical practices and human rights while engaging with stakeholders for shared success. Initiatives such as the Sustainability Advisory Board aim to drive responsible practices across different domains.

Recent Innovations and Milestones

Fresenius has pioneered several groundbreaking therapies, including CAR-T cell therapy, which leverages genetically modified cells for innovative cancer treatments. Their state-of-the-art Lovo and Cue cell processing systems have contributed significantly to achieving better patient outcomes, reinforcing Fresenius's role as a leader in medical advancements.

Commitment to Improved Patient Care

At Fresenius, the core mission focuses on saving and improving human lives. The company actively works towards enhancing patient care through their products while providing vital services for chronically and critically ill patients. Their sustained commitment is evident in their robust performance and successful growth trajectory seen throughout 2024 and into 2025.

Conclusion

Fresenius stands at the forefront of healthcare innovation, guided by its commitment to quality and patient-centric solutions. The company's proactive approach in addressing the needs of the healthcare ecosystem positions it strongly for the future, contributing to better health outcomes globally.